Overview
Federal Regulations
All
Driver
Vehicle
Company
FMCSA Hazmat
Regulatory Guidance
Rulemakings and Notices
Final Rules
Interim Final Rules
Proposed Rules
Notices
Topics of Interest
Hours-of-Service (HOS) Summary
Distracted Driving
Hazardous Materials
Intermodal Equipment Providers (IEP)
New Entrant Safety Assurance
Medical Program
Medical Expert Panels
NAFTA Rules
Drug & Alcohol Testing
 
  
 

Interpretation for 382.213:

Regulations current to Aug 30, 2012
         
Examples: Medical Form, 391.53, 391
 
Up All Regulations
Up Part 382
 
< 382.211 382.215 >
Subpart B - Prohibitions

§382.213 Controlled substances use.

Question 1: Must a physician specifically advise that substances in a prescription will not adversely affect the driver’s ability to safely operate a Commercial Motor Vehicle (CMV) or may a pharmacist’s advice or precautions printed on a container suffice for the advice?

Guidance: A physician must specifically advise the driver that the substances in a prescription will not adversely affect the driver’s ability to safely operate a Commercial Motor Vehicle (CMV).


 
 
Connect with us
FMCSA's Contact Us  FMCSA's Facebook page

Feedback | Privacy Policy | USA.gov | Freedom of Information Act (FOIA) | Accessibility | OIG Hotline | Web Policies and Important Links | Site Map | Plug-ins

Federal Motor Carrier Safety Administration
1200 New Jersey Avenue SE, Washington, DC 20590 • 1-800-832-5660 • TTY: 1-800-877-8339 • Field Office Contacts